Cognition Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell CGTX and other ETFs, options, and stocks.About CGTX
Cognition Therapeutics, Inc. is a clinical stage neuroscience company which engages in developing drugs that help restore normal cellular damage responses in neurodegenerative and neuro-ophthalmic disorders. It offers the CT1812 which aims to restore the damaged cellular processes that drive diseases such as Alzheimer’s disease, dry age-related macular degeneration, geographic atrophy and other conditions.
CEOLisa R. Ricciardi
CEOLisa R. Ricciardi
Employees28
Employees28
HeadquartersPurchase, New York
HeadquartersPurchase, New York
Founded2007
Founded2007
Employees28
Employees28
CGTX Key Statistics
Market cap76.05M
Market cap76.05M
Price-Earnings ratio-2.25
Price-Earnings ratio-2.25
Dividend yield—
Dividend yield—
Average volume121.03K
Average volume121.03K
High today$1.97
High today$1.97
Low today$1.87
Low today$1.87
Open price$1.93
Open price$1.93
Volume55.06K
Volume55.06K
52 Week high$3.49
52 Week high$3.49
52 Week low$0.9001
52 Week low$0.9001